AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

ACIDE HYALURONIQUE

9 registrations across 2 African markets— 8 active

Markets with ACIDE HYALURONIQUE

Recent registrations

Brand / ProductMarketHolderStatusExpires
POYFRESH COLLYRE 0,2% SOLUTION OPHTALMIQUE STERILE. FLACON DE 10ML🇨🇮Côte d'IvoireORCHIDIA PHARMACEUTICAL INDUSTRIESexpiredDec 2023
AQUALARM UP
collyre / 0,24%
🇸🇳SenegalBAUSHactive
VISMED GEL
collyre en ampoule / 0,003
🇸🇳SenegalTRBactive
AQUALARM UD
collyre / 0,20%
🇸🇳SenegalBAUSHactive
MUVAGEL
gel dermique / 0,1 %
🇸🇳SenegalENVENCIAactive
AQUALARM UD
collyre / 0,20%
🇸🇳SenegalBAUSHactive
AQUALARM UP
collyre / 0,24%
🇸🇳SenegalBAUSHactive
VISMED GEL
collyre en ampoule / 0,003
🇸🇳SenegalTRBactive
MUVAGEL
gel dermique / 0,1 %
🇸🇳SenegalENVENCIAactive

ACIDE HYALURONIQUE in Africa — Regulatory Overview

ACIDE HYALURONIQUE is registered across 2 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Côte d'Ivoire. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 8 (89%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.